`panacea biotec, Pharmaceutical company

Biotechnology major Panacea Biotec said on Wednesday it is collaborating with Refana Inc of the United States to make a COVID-19 vaccine widely accessible around the world in an equitable manner through a joint venture company to be based in Ireland.The collaboration aims to bring to patients a whole inactivated virus-based vaccine for COVID-19. Under the collaboration, Panacea Biotec will be responsible for product development and commercial manufacturing with the joint venture undertaking clinical development and regulatory submissions across the world.Both Panacea and Refana will undertake sales and distribution of the vaccine in their respective territories."The world needs a vaccine that is safe, effective, and scalable in a current good manufacturing practice (cGMP) compliant manufacturing facility which has sizeable capacity and capability to cater to global demand," said Panacea Biotec's Managing Director Rajesh Jain."Our collaboration with Refana aims to manufacture over 500 million doses of our COVID-19 candidate vaccine with over 40 million doses expected to be available for delivery early next year," he said in a statement.Jain said whole inactivated viral vaccines have a higher probability of being safe and efficacious, given their long history and a better understanding of their mechsm of action, which has been elucidated over many decades."This vaccine has the potential to become the vaccine of choice for the global fight against COVID-19. We believe and hope that our vaccine will enable the world to get back to work fearlessly as soon as possible," he said.Panacea Biotec focuses on discovery, development and commercialisation of prescription medicines. Its facilities are WHO prequalified, US FDA approved and cGMP compliant. It is also undertaking the development of a novel tetravalent dengue vaccine, pneumococcal conjugate vaccine among other differentiated drug development programmes.In April 2019, India Resurgence Fund (IndiaRF), a leading India-focused investment platform promoted by Piramal Enterprises and Bain Capital Credit, announced an investment of up to Rs 992 crore in Panacea Biotec.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

`panacea BiotecFOLLOW

`panacea biotec, Latest News

National :DCGI gives nod to Panacea Biotec to manufacture Sputnik V jabs

The Drug Controller General of India (DCGI) has approved biotechnology company Panacea Biotec to manufacture Russian 'Sputnik-V' vaccine in ... ...

National :Delhi HC anguished over shortage of COVID vaccines in India

The Delhi High Court on Friday expressed anguish over COVID-19 vaccine shortage and "the way things have transpired during the second wave". ...

International :Russia getting requests from Indian states for Sputnik V vaccine supply, all proposals being studied carefully: Dy envoy

Russia is getting requests from Indian states and companies for the supply of Sputnik V vaccines, said Russian Deputy Envoy Roman Babushkin, adding that "all proposals" are being studied "very carefully". ...

International :RDIF, Panacea Biotec launch production of Sputnik V COVID-19 vaccine in India

The Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, on Monday launched the production of the Sputnik V COVID-19 vaccine. ...

International :COVID-19: RDIF collabs with Panacea Biotec to produce 100 million doses of Sputnik V vaccine in India

One of India's largest vaccine and pharmaceutical company 'Panacea Biotec' in collaboration with the Russian Direct Investment Fund (RDIF) has agreed to produce 100 million doses per year of COVID-19 vaccine Sputnik V, the world's first registered va ...

Business :Panacea Biotec to collaborate with US-based Refana Inc for COVID-19 vaccine

Biotechnology major Panacea Biotec said on Wednesday it is collaborating with Refana Inc of the United States to make a COVID-19 vaccine widely accessible around the world in an equitable manner through a joint venture company to be based in Ireland. ...